
View larger version (38K):
[in this window]
[in a new window]
|
Fig. 4. Lamin proteins are retained in purified nucleoli. (A-C) Immunoblotting was used to monitor the relative concentration of the A- and B-type lamin proteins in nuclear fractions isolated from HeLa cells. Different nuclear fractions (N, nucleus; NE, nuclear envelope; NM, nuclear matrix; No, nucleolus) were isolated using established protocols. (A) As a quality control, isolated nucleoli (nucleolus extract) were shown to retain the same size, structure and organization as the nucleoli of untreated cells (whole cell) when analyzed by indirect immunostaining. Bright-field images (left) and optical sections (right) are shown together with a 2x magnification of a typical nucleolus (middle row, from boxed areas in the top row) to show that the fibrillarin-stained active centers (Fib, green) and nucleophosmin-stained granular component (Nucleoph, red) are maintained throughout isolation; the separation of active sites was determined as described (see Fig. 2 legend). (B,C) Following purification, nuclear fractions (7 µg/lane) were separated by gel electrophoresis and the presence of A- and B-type lamins was determined by immunoblotting (left). The same approach was applied to isolated nucleoli after treating cells for 2 hours with DRB or actinomyicn D (Act. D), using untreated controls (Ct) for comparison (right). The changes in the lamin protein concentration (C) were assessed by calculating the intensity ratio of lamin B1 (LB1) relative to lamin A and C (LA/C). Note that although this analysis shows the relative content of A- and B-type lamins in different fractions, it is not designed to provide a quantitative distribution of the proteins during fractionation (see text). Based on the cell numbers used and the product yields, nucleoli contain <2% of the lamin polypeptides in HeLa cells. Scale bars: 5 µm.
|